We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
International stocks trading in New York were mixed on Wednesday. The Bank of New York index of American depositary receipts fell 0.06% to 157.55. The European index decreased 0.07% to 154.95, the Asian index improved 0.24% to 152.43, the Latin American index fell 1% to 309.10 and the emerging markets index decreased 0.08% to 303.77. Among the companies with shares that actively traded was GlaxoSmithKline PLC (GSK, GSK.LN).
GlaxoSmithKline PLC (GSK, GSK.LN) downgraded its earnings outlook for the full year, as its second-quarter profits were hit by weak respiratory-drug sales in the U.S., currency moves and a continuing bribery investigation in China. Shares fell 6% to $50.04.
ABB Ltd. (ABB, ABBN.VX, ABB.SK) reported weaker-than-expected second-quarter earnings as the Swiss engineering giant's performance was weighed down by its power systems division. However, total orders were up 13.47% in the quarter to $10.58 billion. Shares rose 1.5% to $23.79.
Write to Tess Stynes at tess.stynes@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions